KOSPI Starts Above 2200... Strong Performance of Samsung Affiliates

On the morning of the 9th, the KOSPI index, which started 1% higher than the previous day, along with the won/dollar exchange rate, is displayed on the electronic board in the Hana Bank dealing room in Jung-gu, Seoul. (Photo by Yonhap News)

[Asia Economy Reporter Kum Boryeong] On the 9th, the KOSPI index surpassed the 2200 mark.

As of 9:20 AM that day, the KOSPI index recorded 2209.01, up 24.72 points from the previous close.

The KOSPI opened at 2206.23, up 21.94 points (1.00%) from the previous trading day, and continued its strong performance.

In the securities market, institutions were net buyers of 13.7 billion KRW, while individuals and foreigners were net sellers of 9.1 billion KRW and 13 billion KRW, respectively.

By sector, food and beverages (0.49%), electrical and electronics (1.23%), and transportation equipment (0.75%) rose, while machinery (0.71%) declined.

Among the top 10 companies by market capitalization, Samsung Electronics (1.28%), Samsung Biologics (1.2%), Samsung SDI (3.33%), SK Hynix (0.22%), and LG Chem (0.23%) rose, while NAVER (0.42%) declined.

Seosangyoung, a researcher at Kiwoom Securities, analyzed, "The Korean stock market is expected to continue showing differentiation by index direction, sector, and individual stocks based on foreign futures trends amid a cautious stance awaiting the Federal Open Market Committee (FOMC)."

The KOSDAQ also rose 2.34 points (0.31%) from the previous day to 755.38.

The KOSDAQ opened at 756.02, up 2.98 points (0.40%) from the previous close, and maintained its strong performance.

In the KOSDAQ market, individuals and institutions were net buyers of 6.4 billion KRW and 2 billion KRW, respectively, while foreigners were net sellers of 2.9 billion KRW.

By sector, IT components (1.03%) and food and tobacco (1.17%) rose, while textiles and apparel (0.64%) declined.

Among the top market cap companies, CJ ENM (0.65%), EcoPro BM (3.12%), and Studio Dragon (1.12%) rose, while HLB (0.45%), Celltrion Pharm (1.73%), and Alteogen (3.62%) declined.

This content was produced with the assistance of AI translation services.